Market Tracker

05/26 6:49am ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

6.73
Delayed Data
As of May 25
 +1.60 / +31.19%
Today’s Change
2.60
Today|||52-Week Range
9.25
+6.32%
Year-to-Date

Today’s Trading

Previous close5.13
Today’s open6.25
Day’s range6.15 - 7.39
Volume27,438,930
Average volume (3 months)1,837,635
Market cap$541.2M
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+2.37%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book314.63

Competitors

 Today’s
change
Today’s
% change
ANABAnaptysBio Inc+0.28+1.06%
AUPHAurinia Pharmaceutic...-0.33-4.77%
ANIPANI Pharmaceuticals ...+0.59+1.26%
SGMOSangamo Therapeutics...-0.35-4.29%
Data as of 05/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts